A Phase II Study of Decitabine in Patients With Chronic Myelomonocytic Leukemia.
Phase of Trial: Phase II
Latest Information Update: 15 Jun 2014
At a glance
- Drugs Decitabine (Primary)
- Indications Chronic myelomonocytic leukaemia
- Focus Therapeutic Use
- 28 Nov 2011 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.
- 28 Nov 2011 Actual initiation date (Nov 2008) added as reported by ClinicalTrials.gov.
- 07 Apr 2010 New trial record